ACXP - CIK 0001736243
Acurx Pharmaceuticals, Inc. has filed 232 documents with the SEC between 2018 and 2026. The most frequent type is insider trade (51 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| 424B3 | - | 2026-05-12 | - |
| 424B3 | - | 2026-05-12 | - |
| EFFECT | - | 2026-05-11 | - |
| EFFECT | - | 2026-05-11 | - |
| Quarterly report | 10-Q | 2026-05-11 | 2026-03-31 |
| IPO registration | S-1 | 2026-05-04 | - |
| IPO registration | S-1 | 2026-05-04 | - |
| D | - | 2026-04-29 | - |
| Insider trade | 4 | 2026-04-22 | 2026-04-20 |
| Insider trade | 4 | 2026-04-22 | 2026-04-20 |
| Insider trade | 4 | 2026-04-22 | 2026-04-20 |
| Insider trade | 4 | 2026-04-22 | 2026-04-20 |
| Insider trade | 4 | 2026-04-22 | 2026-04-20 |
| Insider trade | 4 | 2026-04-22 | 2026-04-20 |
| Insider trade | 4 | 2026-04-22 | 2026-04-20 |
| Insider trade | 4 | 2026-04-22 | 2026-04-20 |
| Major company event | 8-K | 2026-04-16 | 2026-04-15 |
| Prospectus supplement | 424B5 | 2026-04-16 | - |
| Employee stock plan | S-8 | 2026-03-12 | - |
| Annual report | 10-K | 2026-03-12 | 2025-12-31 |
| Major company event | 8-K | 2026-03-09 | 2026-03-09 |
| EFFECT | - | 2026-02-11 | - |
| 424B3 | - | 2026-02-11 | - |
| Company correspondence | CORRESP | 2026-02-09 | - |
| SEC correspondence | UPLOAD | 2026-02-09 | - |
| IPO registration | S-1 | 2026-02-02 | - |
| EFFECT | - | 2026-01-06 | - |
| Company correspondence | CORRESP | 2026-01-02 | - |
| S-3/A | - | 2025-12-30 | - |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| Quarterly report | 10-Q | 2025-11-12 | 2025-09-30 |
| 424B3 | - | 2025-11-10 | - |
| IPO registration | S-1 | 2025-10-20 | - |
| Major company event | 8-K | 2025-09-22 | 2025-09-22 |
| Major company event | 8-K | 2025-09-19 | 2025-09-16 |
| SCHEDULE 13G | - | 2025-08-14 | - |
| Quarterly report | 10-Q | 2025-08-11 | 2025-06-30 |
| Proxy materials | DEFA14A | 2025-08-05 | - |
| Proxy statement | DEF 14A | 2025-08-04 | 2025-09-16 |
| Major company event | 8-K | 2025-07-31 | 2025-07-31 |
| PRE 14A | - | 2025-07-24 | 2025-09-16 |
| EFFECT | - | 2025-07-23 | - |
| Company correspondence | CORRESP | 2025-07-21 | - |
| SEC correspondence | UPLOAD | 2025-07-21 | - |
| Major company event | 8-K | 2025-07-17 | 2025-07-17 |
| IPO registration | S-1 | 2025-07-15 | - |
| SEC correspondence | UPLOAD | 2025-07-14 | - |
| Securities registration | S-3 | 2025-07-09 | - |
| D | - | 2025-06-27 | - |
| Major company event | 8-K | 2025-06-20 | 2025-06-17 |